Michelle Wolff, RD brings a nutrition-centered perspective to weight management that blends practical guidance with a clear understanding of the science behind newer medications such as tirzepatide, including Zepbound. Her work addresses a common frustration in weight-loss care: when progress slows or a medication does not seem to be delivering the expected results. Rather than treating that stall as a mystery, the focus is on understanding the underlying factors and identifying realistic next steps.
That approach is grounded in both education and action. Attention is given to how tirzepatide works, why weight loss may taper, and what can influence outcomes over time. Diet, dosage timing, and day-to-day habits are treated as meaningful variables rather than afterthoughts, with an emphasis on helping people make sense of what is happening in their bodies and how to adjust accordingly.
The tone of care is expert but pragmatic. Weight management is approached not as a one-note pursuit of the scale, but as an ongoing process that benefits from informed nutrition support, especially when medication is part of the picture. Questions such as how much weight can be lost on tirzepatide, or why progress has slowed, are met with a combination of scientific context and usable strategies.
Michelle Wolff is also connected with Fay, which links clients with registered dietitians and works directly with insurance companies to make nutrition care easier to access and more affordable. That accessibility complements a style of care centered on clarity, evidence, and practical momentum.
Michelle Wolff, RD
28 Bedford St
New York, NY 10014
Is this your business?